Clinical Trials Logo

Clinical Trial Summary

The aim of PLUS is to conduct a multi-centre, blinded, randomised, controlled trial (RCT) to determine whether fluid resuscitation and therapy with a "balanced" crystalloid solution (Plasma-Lyte 148®) decreases 90-day mortality in critically ill patients requiring fluid resuscitation when compared with the same treatment using 0.9% sodium chloride (saline)


Clinical Trial Description

Fluid resuscitation is a fundamental component of the management of acutely and critically ill patients and the choice of fluid is a longstanding issue of debate. Worldwide, 0.9% saline has traditionally been the most widely used resuscitation fluid, however its use is increasingly challenged by emerging evidence that suggests its high chloride content may have clinically important adverse effects and that resuscitation with so-called "balanced" or "buffered" crystalloids (such as Plasma-Lyte 148®) offer patients better outcomes. Given the limitations of current evidence, there is now a scientific, ethical and health economic imperative to provide an accurate and reliable estimate of the comparative risks versus benefit of Plasma-Lyte 148® versus 0.9% saline. The PLUS study is a prospective, multi-centre, parallel group, concealed, blinded, randomised, controlled trial. The study will test the hypothesis that in a heterogeneous population of critically ill adults, random assignment to Plasma-Lyte 148® for intravascular volume resuscitation and crystalloid fluid therapy in the Intensive Care Unit (ICU) results in different 90-day all-cause mortality when compared with random assignment to 0.9% sodium chloride (saline) for the same treatment. Each patient who meets all inclusion criteria and no exclusion criteria will be randomised to receive either Plasma-Lyte 148® or 0.9% saline for all resuscitation episodes and for all compatible crystalloid therapy while in ICU for up to 90 days after randomisation. Other crystalloid fluids may be used as carrier fluids for the infusion of any drug for which either Plasma-Lyte 148® or 0.9% saline is considered incompatible.The study treatments will be supplied in identical 1000 ml bags and treatment assignment will be concealed. The volume of study fluid being administered will be titrated against clinical endpoints determined by the treating clinicians and reviewed as clinically appropriate during the period of resuscitation and ICU treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02721654
Study type Interventional
Source The George Institute
Contact
Status Completed
Phase Phase 4
Start date September 1, 2017
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Suspended NCT02315937 - Hemodynamic Assessment During Spinal Anesthesia Using Transthoracic Echocardiography' N/A
Active, not recruiting NCT01681238 - Goal-directed Therapy in High-risk Surgery N/A
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Recruiting NCT05557461 - Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?
Withdrawn NCT03246425 - Influence of Mechanical Ventilation Mode on Arterial Pressure Variations- a Pilot Study N/A
Not yet recruiting NCT06072430 - VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients (VBI-S-02) Phase 2/Phase 3
Completed NCT02903316 - Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles N/A
Completed NCT03009305 - Cerebral Oximetry in Lower Body Negative Pressure N/A
Completed NCT01456559 - Detection of Hypovolemia Using Pleth Variability Index (PVI) N/A
Completed NCT00380107 - Volume Deficit Prior to Surgery Phase 4
Recruiting NCT06123039 - Use of Heart-lung Interaction to Predict Haemodynamic Tolerance to the Open Lung Approach With Individualised PEEP
Completed NCT04573842 - Ultrasound Assessment of the Subclavian Vein for Predicting Hypotension in Children After Anaesthesia Induction
Completed NCT05150418 - Supplemental Oxygen in Hypovolemia Phase 1
Completed NCT02961439 - Validation of Epworth Richmond's Echocardiography Education Focused Year N/A
Completed NCT01535703 - Comparison of Cardiac Output Measurement Between Transpulmonary Thermodilution and Photoplethysmography N/A
Completed NCT01010022 - Trial of 6% HES130/0.4 Phase 3
Completed NCT04641949 - Methoxyflurane and Fentanyl in LBNP Phase 4
Recruiting NCT03592290 - Hemodynamics Monitoring During Lower Body Negative Pressure (LBNP) Induced Controlled Hypovolemia
Suspended NCT03736421 - Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients
Completed NCT02679625 - Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients